ctrl K

Watchlist Price Alert

Comera Life Sciences Inc... (CMRA)

OTC: CMRA · Real-Time Price · USD

0.00

-0.00 (-100.00%)

At close: Mar 26, 2025, 12:42 PM

Comera Life Sciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	633.1K	319.83K	442.92K
Cost of Revenue	210.39K	161.01K	104.41K
Gross Profit	422.71K	158.82K	338.51K
Operating Income	-11.97M	-5.54M	-2.13M
Interest Income	n/a	n/a	n/a
Pretax Income	-18M	-5.45M	-2.13M
Net Income	-18M	-5.29M	-2.13M
Selling & General & Admin	10.65M	3.94M	1.2M
Research & Development	1.74M	1.75M	1.26M
Other Expenses	n/a	-76.74K	2.03K
Operating Expenses	12.39M	5.69M	2.47M
Interest Expense	20.39K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	12.6M	5.86M	2.57M
Income Tax Expense	n/a	-160.59K	-116.55K
Shares Outstanding (Basic)	10.45M	19.09M	19.09M
Shares Outstanding (Diluted)	10.45M	19.09M	19.09M
EPS (Basic)	-1.76	-0.28	-0.11
EPS (Diluted)	-1.76	-0.28	-0.11
EBITDA	-17.89M	-5.36M	-2.04M
EBIT	-17.98M	-5.45M	-2.13M
Depreciation & Amortization	93.95K	88.82K	89.75K